TORONTO, Feb. 04, 2021 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis is pleased to announce its terpene-infused, one-gram Saturday Cannabis (“Saturday”) vaporizer (“vapes”) was recently named “Top Selling Vape” for the month of January, 2021 at the Ontario Cannabis Store (“OCS”), Canada’s largest cannabis retail distributor. When compared to over 30 available brands, according to OCS-provided data, Saturday ranked first in the one-gram category and when compared to all other vapes sizes, it ranked in the “OCS Top 4”.
The Company also confirmed its Color Cannabis products are now available in 15 gram nitrogen-infused pouches through the OCS, in award-winning strains such as Pedro’s Sweet Sativa, Ghost Train Haze, and Black Sugar Rose. Additionally, starting this month, WeedMD will be shipping Boveda humidity control packs with all of its dried flower products across Canada to preserve the freshness and terpene-profiles for which WeedMD products are recognized.
“This is expected to be a breakout year for our Saturday Cannabis and Color Cannabis adult-use product lines as consumers in Canada’s largest retail market purchase our terpene-rich, quality-derived products and help expand our brand recognition nationally,” said Joseph Mele, Senior Vice President, Commercial Sales & Marketing, WeedMD. “Market feedback is paramount to our success and Ontario provides a discerning audience for our flavour-rich products. Our teams take this valuable consumer input and apply it to everything from our product offerings, packaging innovation and freshness control and we’re proud of the new line-up being released nationally in the coming months.”
In addition to Saturday Cannabis vapes available in Sour Pineapple and Lemon Haze, WeedMD also produces strain-specific Color Cannabis vapes, in Pedro Sweet Sativa and Ghost Train Haze. All vape products are produced at the Company’s state-of-the-art extraction hub in Aylmer, ON utilizing WeedMD’s own terpene-rich indoor and outdoor biomass.
The Company is also the exclusive Canadian supplier and distributor of acclaimed U.S.-based wellness house Mary’s Medicinals, with topicals production underway at WeedMD’s extraction hub. A product update will be provided in the coming weeks, with products expected to launch in the first quarter of 2021.
Access WeedMD’s 2021 Shareholder Newsletter here. Updated investor presentation and corporate deck can be found here.
About WeedMD Inc.
WeedMD Inc. is the publicly traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., licence holders producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, ON as well as a fully-licensed 26,000 sq. ft. Aylmer, ON processing facility, specializing in cannabis extraction. With the addition of Starseed, a medical-centric operator, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships in the seniors’ market and supply agreements with Shoppers Drug Mart as well, as seven provincial distribution agencies where adult-use brands Color Cannabis and Saturday are sold.
Follow WeedMD and its brands on LinkedIn
For further information, please contact:
For Investor Enquiries:
KCSA Strategic Communications
For Media Enquiries:
VP, Communications & Corporate Affairs
Forward Looking Information This press release contains „forward-looking information” within the meaning of applicable Canadian securities legislation which are based upon WeedMD’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as „expect”, „likely”, „may”, „will”, „should”, „intend”, „anticipate”, „potential”, „proposed”, „estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions „may”, „would” or „will” happen, or by discussions of strategy.
The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; the COVID-19 pandemic; competition; crop failure; and other risks.
Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD’s disclosure documents filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE